Cells, cytokines and inflammatory bowel disease: a clinical perspective.
about
The role of physical exercise in inflammatory bowel diseaseCytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysisLaboratory markers in ulcerative colitis: Current insights and future advancesTh1/Th2 Balance and Th17/Treg-Mediated Immunity in relation to Murine Resistance to Dextran Sulfate-Induced ColitisGrowth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation.Alternative medicines as emerging therapies for inflammatory bowel diseases.Evaluation of selected cytokine gene expression in colonic mucosa from dogs with idiopathic lymphocytic-plasmacytic colitis.Molecular mechanism of protopanaxadiol saponin fraction-mediated anti-inflammatory actions.Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel diseaseCardiovascular complications in inflammatory bowel disease.Assessment of histologic disease activity in Crohn's disease: a systematic review.Anti-inflammatory effects of Hwang-Heuk-San, a traditional Korean herbal formulation, on lipopolysaccharide-stimulated murine macrophages.Oral administration of fermented wild ginseng ameliorates DSS-induced acute colitis by inhibiting NF-κB signaling and protects intestinal epithelial barrierAnti-inflammatory and antioxidative effects of six pentacyclic triterpenes isolated from the Mexican copal resin of Bursera copalliferaSTAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.The role of Klebsiella in Crohn's disease with a potential for the use of antimicrobial measuresSleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation.Effects of probiotics on Toll‑like receptor expression in ulcerative colitis rats induced by 2,4,6‑trinitro‑benzene sulfonic acid.Immune-epithelial crosstalk at the intestinal surface.Remote ischemic preconditioning as treatment for non-ischemic gastrointestinal disorders: beyond ischemia-reperfusion injury.Challenges and Opportunities in the Development of Aptamers for TNFα.Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling.Inhibitory effects of 3α-hydroxy-lup-20(29)-en-23, 28-dioic acid on lipopolysaccharide-induced TNF-α, IL-1β, and the high mobility group box 1 release in macrophages.Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.Anti-inflammatory effects of a casein hydrolysate and its peptide-enriched fractions on TNFα-challenged Caco-2 cells and LPS-challenged porcine colonic explants.Adiponectin confers protection from acute colitis and restricts a B cell immune response.The Rhizome Mixture of Anemarrhena asphodeloides and Coptis chinensis Attenuates Mesalazine-Resistant Colitis in Mice.Anti-inflammatory activity of AP-SF, a ginsenoside-enriched fraction, from Korean ginsengInterleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis.A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.Serum IL-17 and IL-6 increased accompany with TGF-β and IL-13 respectively in ulcerative colitis patientsSteroid-sparing strategies in the management of ulcerative colitis: efficacy of leukocytapheresis.An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease.Potential of the plant Thespesia populnea in the treatment of ulcerative colitis.Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation.Piroxicam treatment augments bone abnormalities in interleukin-10 knockout mice.Development of a synthetic receptor protein for sensing inflammatory mediators interferon-γ and tumor necrosis factor-α.Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.The pre-treatment characteristics and evaluation of the effects of recombinant human growth hormone therapy in children with growth hormone deficiency and celiac disease or inflammatory bowel disease.
P2860
Q26865777-BC58912A-B19C-42A5-85A1-ED746BDBACC3Q27011652-1FA0A1F6-BB42-4E23-87EA-1A8CD0E8DC7EQ27027022-BA619400-5A12-4780-A418-2CA2B4C41DC5Q33726361-FC72DB14-77D0-4BB9-B1DD-EEE556FCE63AQ33755171-BDCDF238-504F-462E-AF01-696C6EB9AEA0Q33758636-63CC57D1-6725-4B8D-8C0E-FFB8CB4F8894Q34069427-4B4433F5-069A-49BF-9220-524667672A8EQ34456956-D666D831-2668-48B4-B3E3-8C0EE0098D75Q34719329-85D3C2F8-0BB8-4A1D-9B74-28AB4E77C30EQ34827250-294ACFC2-2E00-4884-963C-D236748CEE71Q35197222-4F07F23A-B0B2-48CB-8E80-35646E962A4BQ35228055-6306694F-A8BC-4109-AACD-210F86C51253Q35876575-FF11891D-8C29-4777-85BF-676F98B46DECQ36079476-F569DE9C-2E2F-4A02-BC9B-3597E8B0B99FQ36175370-03BFC0C4-593C-412B-9D38-3463D381D1B2Q36498298-F6F3E0B0-8418-403E-8DC3-E15FD830B0E4Q37260906-C281A5A6-0F2F-4ECF-A4E0-53B2B3E1C84BQ37715916-4AE2F390-B0BD-4A3F-A224-456FBB608AAAQ37720200-D5D8FB1B-566F-4DF9-8ECF-B2BDF392BA53Q38182446-12F55A90-5E76-4598-83C3-99343E538D84Q38202633-69056600-C863-485A-8A2F-610A768EBF75Q38293540-0C962F92-DFF9-42DA-9DB7-06E20D130FBEQ38638660-C5557700-7396-40BF-B22E-C4217FA38A8BQ38710431-237E22BD-EACE-4D92-8019-80F3DBA7A308Q38927751-3DE77DCA-7EDD-42CF-AE84-34F862E7EF43Q38930230-8A7508C3-46B2-410F-8B0D-084E79DFB9E5Q38930497-F56D98BF-7BF6-47B3-AF22-32F706EDC0E9Q41430241-CF45CA25-D703-4AB0-BD06-5D8D9A427CD9Q41577043-6DE17D93-09D0-4392-8361-49BCD679EB8AQ41672388-06C67055-C849-49A2-9101-9CD9B8D4AAE5Q41956191-69A2922E-A52B-442A-8790-D3EC4CA29A43Q41985685-6B1D1768-ACF6-4B27-BDF8-B8BDF0A46C2FQ42361175-EB1167D8-7448-4DD7-A5B2-22BA25A02834Q43951967-413492CB-0A12-4AD0-BF69-9F8093BF67ECQ46746015-AD2C3A0C-1DAD-4849-B1BA-E895603292BEQ49339629-C1572735-E1EC-4C81-8102-73D5EABF32A7Q50609014-80526245-9627-4A32-AE4B-0B3B26B11D5BQ51720186-05209CD3-52D7-4DF9-BECE-7FBB24E0C93FQ53083936-CF16A84E-3483-4706-8F30-D7807888A19DQ54939588-654A1D6C-D7B8-4760-846D-359CD4A996B2
P2860
Cells, cytokines and inflammatory bowel disease: a clinical perspective.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cells, cytokines and inflammatory bowel disease: a clinical perspective.
@en
Cells, cytokines and inflammatory bowel disease: a clinical perspective.
@nl
type
label
Cells, cytokines and inflammatory bowel disease: a clinical perspective.
@en
Cells, cytokines and inflammatory bowel disease: a clinical perspective.
@nl
prefLabel
Cells, cytokines and inflammatory bowel disease: a clinical perspective.
@en
Cells, cytokines and inflammatory bowel disease: a clinical perspective.
@nl
P2093
P2860
P356
P1476
Cells, cytokines and inflammatory bowel disease: a clinical perspective.
@en
P2093
Adrian G Cummins
Ian C Roberts-Thomson
Wendy Uylaki
P2860
P304
P356
10.1586/EGH.11.74
P50
P577
2011-12-01T00:00:00Z